StonvexLoading…
StonvexStonvexStonvexCore line items from NP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $159.55M | $119.30M | $84.87M |
Operating Income | $70.95M | $68.45M | $45.43M |
Net Income | $37.41M | $34.59M | $17.89M |
EPS (Diluted) | $-0.26 | $0.16 | $0.10 |
Total Assets | $65.30M | $48.15M | Not available |
Total Liabilities | $292.79M | $173.67M | Not available |
Cash & Equivalents | $8.04M | $7.09M | $24.32M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available |
Shares Outstanding | 104.50M | 93.35M | 93.52M |